Wm Gordon Prescott - 29 Aug 2025 Form 4 Insider Report for Beacon Financial Corp (BHLB)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
03 Sep 2025, 11:10:32 UTC
Prior SEC filing
05 Mar 2025
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Marc Levy, pursuant to power of attorney

Key filing fact

Wm Gordon Prescott filed Form 4 for Beacon Financial Corp (BHLB) on 03 Sep 2025.

Key facts

  • This page summarizes Wm Gordon Prescott's Form 4 filing for Beacon Financial Corp (BHLB).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 03 Sep 2025, 11:10.

Change

  • Previous filing in this sequence was filed on 05 Mar 2025.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001757640 Primary reporting owner

Prescott Wm Gordon

Relationship
General Counsel and Corp Sec
Address
131 CLARENDON STREET, BOSTON
Signature
/s/ Marc Levy, pursuant to power of attorney
Signature date
03 Sep 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

BBT transaction

Common Stock

Award

Transaction value
$0
Shares
+5,902
Change %
+26%
Price
$0.000000
Shares after
28,584
Date
29 Aug 2025
Ownership
Direct
Footnotes
F3, F4, F5
BBT holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
0
Date
29 Aug 2025
Ownership
By Stock Award IX
Footnotes
F2, F3
BBT holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
0
Date
29 Aug 2025
Ownership
By Stock Award VIII
Footnotes
F1, F3
BBT holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
2,644
Date
29 Aug 2025
Ownership
By 401(k)
Footnotes
F6
BBT holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
1,310
Date
29 Aug 2025
Ownership
By IRA
Footnotes
F6
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 6 footnotes

Footnote F1

Stock Awards granted pursuant to the Berkshire Hills Bancorp, Inc. 2022 Equity Compensation Plan vest in three equal annual installments beginning on January 30, 2024.

Footnote F2

Stock Awards granted pursuant to the Berkshire Hills Bancorp, Inc. 2022 Equity Compensation Plan vest in three equal annual installments beginning on January 30, 2025.

Footnote F3

Since the reporting person's last report, 593 shares previously held through Stock Award VIII and 1,438 shares previously held through Stock Award IX have vested and are now owned directly.

Footnote F4

On January 30, 2023 the reporting person was granted 2,668 shares of restricted stock subject to a three-year cliff vesting schedule and subject to the satisfaction of certain performance criteria. The shares vested at 100% of target, resulting in the vesting of 2,668 shares of restricted stock, and were transferred to the executive on August 29, 2025.

Footnote F5

On January 30, 2024 the reporting person was granted 3,234 shares of restricted stock subject to a three-year cliff vesting schedule and subject to the satisfaction of certain performance criteria. The shares vested at 100% of target, resulting in the vesting of 3,234 shares of restricted stock, and were transferred to the executive on August 29, 2025.

Footnote F6

Reflects transactions not required to be reported pursuant to Section 16 of the Securities Exchange Act of 1934, as amended.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .